** Medical imaging software provider Pro Medicus PME.AX gains 1.6% to A$257.85; set for its biggest intraday pct gain since Jan. 9
** Jefferies retains "hold"; raises PT to A$250
** Says co can secure significant earnings growth despite lofty ~A$250/shr valuation, implying 98% U.S. radiology market penetration and demanding near-total market dominance for support
** Revises FY26-27 earnings to 13%-32% ahead of consensus; sees fair value of PME at A$140, implying ~50% U.S. market share
** Says existing customers, such as NYU Langone and Duke University, upgrading to full range of services may boost rev by 24%
** Adds PME's Visage viewer tech outshines newly launched DeepHealth OS Fast Viewer by California-based Radnet RDNT.O
** Stock rated "hold" on avg; median PT is A$237.50 – LSEG
** PME more than doubled in value last year, gaining 161%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。